vs
GE医疗(CCRN)与PROGRESS SOFTWARE CORP(PRGS)财务数据对比。点击上方公司名可切换其他公司
PROGRESS SOFTWARE CORP的季度营收约是GE医疗的1.1倍($252.7M vs $236.8M),PROGRESS SOFTWARE CORP净利率更高(10.2% vs -35.0%,领先45.2%),PROGRESS SOFTWARE CORP同比增速更快(17.5% vs -23.6%),PROGRESS SOFTWARE CORP自由现金流更多($59.9M vs $16.1M),过去两年PROGRESS SOFTWARE CORP的营收复合增速更高(17.0% vs -21.0%)
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业,品牌标识为GE HealthCare。公司主要业务分为四大板块:包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务,以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务,此外还开展医药相关业务。
Progress Software是全球领先的企业级软件服务商,主营应用开发平台、数据连接工具、数字体验解决方案等产品,服务覆盖金融、医疗、制造、零售等多行业的全球企业客户,助力客户搭建高性能可扩展的业务应用,提升运营效率。
CCRN vs PRGS — 直观对比
营收规模更大
PRGS
是对方的1.1倍
$236.8M
营收增速更快
PRGS
高出41.2%
-23.6%
净利率更高
PRGS
高出45.2%
-35.0%
自由现金流更多
PRGS
多$43.8M
$16.1M
两年增速更快
PRGS
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $236.8M | $252.7M |
| 净利润 | $-82.9M | $25.7M |
| 毛利率 | — | 81.6% |
| 营业利润率 | -30.2% | 15.2% |
| 净利率 | -35.0% | 10.2% |
| 营收同比 | -23.6% | 17.5% |
| 净利润同比 | -2109.7% | 2144.6% |
| 每股收益(稀释后) | $-2.56 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CCRN
PRGS
| Q4 25 | $236.8M | $252.7M | ||
| Q3 25 | $250.1M | $249.8M | ||
| Q2 25 | $274.1M | $237.4M | ||
| Q1 25 | $293.4M | $238.0M | ||
| Q4 24 | $309.9M | $215.0M | ||
| Q3 24 | $315.1M | $178.7M | ||
| Q2 24 | $339.8M | $175.1M | ||
| Q1 24 | $379.2M | $184.7M |
净利润
CCRN
PRGS
| Q4 25 | $-82.9M | $25.7M | ||
| Q3 25 | $-4.8M | $19.4M | ||
| Q2 25 | $-6.7M | $17.0M | ||
| Q1 25 | $-490.0K | $10.9M | ||
| Q4 24 | $-3.8M | $1.1M | ||
| Q3 24 | $2.6M | $28.5M | ||
| Q2 24 | $-16.1M | $16.2M | ||
| Q1 24 | $2.7M | $22.6M |
毛利率
CCRN
PRGS
| Q4 25 | — | 81.6% | ||
| Q3 25 | 20.4% | 81.0% | ||
| Q2 25 | 20.4% | 80.1% | ||
| Q1 25 | 20.0% | 80.6% | ||
| Q4 24 | — | 83.0% | ||
| Q3 24 | 20.4% | 83.7% | ||
| Q2 24 | 20.8% | 81.7% | ||
| Q1 24 | 20.4% | 82.2% |
营业利润率
CCRN
PRGS
| Q4 25 | -30.2% | 15.2% | ||
| Q3 25 | -2.4% | 17.6% | ||
| Q2 25 | -2.1% | 16.3% | ||
| Q1 25 | -0.3% | 13.6% | ||
| Q4 24 | -1.1% | 10.0% | ||
| Q3 24 | 0.9% | 22.6% | ||
| Q2 24 | -5.7% | 15.5% | ||
| Q1 24 | 0.8% | 19.0% |
净利率
CCRN
PRGS
| Q4 25 | -35.0% | 10.2% | ||
| Q3 25 | -1.9% | 7.8% | ||
| Q2 25 | -2.4% | 7.2% | ||
| Q1 25 | -0.2% | 4.6% | ||
| Q4 24 | -1.2% | 0.5% | ||
| Q3 24 | 0.8% | 15.9% | ||
| Q2 24 | -4.7% | 9.2% | ||
| Q1 24 | 0.7% | 12.3% |
每股收益(稀释后)
CCRN
PRGS
| Q4 25 | $-2.56 | $0.59 | ||
| Q3 25 | $-0.15 | $0.44 | ||
| Q2 25 | $-0.20 | $0.39 | ||
| Q1 25 | $-0.02 | $0.24 | ||
| Q4 24 | $-0.13 | $0.01 | ||
| Q3 24 | $0.08 | $0.65 | ||
| Q2 24 | $-0.47 | $0.37 | ||
| Q1 24 | $0.08 | $0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $94.8M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $322.8M | $478.3M |
| 总资产 | $449.0M | $2.5B |
| 负债/权益比越低杠杆越低 | — | 2.93× |
8季度趋势,按日历期对齐
现金及短期投资
CCRN
PRGS
| Q4 25 | $108.7M | $94.8M | ||
| Q3 25 | $99.1M | $99.0M | ||
| Q2 25 | $81.2M | $102.0M | ||
| Q1 25 | $80.7M | $124.2M | ||
| Q4 24 | $81.6M | $118.1M | ||
| Q3 24 | $64.0M | $232.7M | ||
| Q2 24 | $69.6M | $190.4M | ||
| Q1 24 | $5.2M | $133.2M |
总债务
CCRN
PRGS
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
CCRN
PRGS
| Q4 25 | $322.8M | $478.3M | ||
| Q3 25 | $408.1M | $477.7M | ||
| Q2 25 | $412.2M | $452.7M | ||
| Q1 25 | $418.2M | $431.8M | ||
| Q4 24 | $419.0M | $438.8M | ||
| Q3 24 | $424.7M | $425.6M | ||
| Q2 24 | $433.3M | $401.7M | ||
| Q1 24 | $462.4M | $461.7M |
总资产
CCRN
PRGS
| Q4 25 | $449.0M | $2.5B | ||
| Q3 25 | $538.2M | $2.4B | ||
| Q2 25 | $553.8M | $2.4B | ||
| Q1 25 | $576.2M | $2.5B | ||
| Q4 24 | $589.3M | $2.5B | ||
| Q3 24 | $597.4M | $1.6B | ||
| Q2 24 | $602.9M | $1.6B | ||
| Q1 24 | $648.4M | $1.5B |
负债/权益比
CCRN
PRGS
| Q4 25 | — | 2.93× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | — | 3.22× | ||
| Q1 25 | — | 3.50× | ||
| Q4 24 | — | 3.48× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $18.2M | $62.8M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $59.9M |
| 自由现金流率自由现金流/营收 | 6.8% | 23.7% |
| 资本支出强度资本支出/营收 | 0.9% | 1.1% |
| 现金转化率经营现金流/净利润 | — | 2.44× |
| 过去12个月自由现金流最近4个季度 | $40.1M | $229.5M |
8季度趋势,按日历期对齐
经营现金流
CCRN
PRGS
| Q4 25 | $18.2M | $62.8M | ||
| Q3 25 | $20.1M | $73.4M | ||
| Q2 25 | $4.2M | $30.0M | ||
| Q1 25 | $5.7M | $68.9M | ||
| Q4 24 | $24.2M | $19.7M | ||
| Q3 24 | $7.5M | $57.7M | ||
| Q2 24 | $82.4M | $63.7M | ||
| Q1 24 | $6.0M | $70.5M |
自由现金流
CCRN
PRGS
| Q4 25 | $16.1M | $59.9M | ||
| Q3 25 | $17.9M | $72.4M | ||
| Q2 25 | $2.3M | $29.5M | ||
| Q1 25 | $3.8M | $67.7M | ||
| Q4 24 | $21.7M | $16.8M | ||
| Q3 24 | $6.3M | $56.6M | ||
| Q2 24 | $79.6M | $62.7M | ||
| Q1 24 | $3.8M | $70.2M |
自由现金流率
CCRN
PRGS
| Q4 25 | 6.8% | 23.7% | ||
| Q3 25 | 7.2% | 29.0% | ||
| Q2 25 | 0.8% | 12.4% | ||
| Q1 25 | 1.3% | 28.4% | ||
| Q4 24 | 7.0% | 7.8% | ||
| Q3 24 | 2.0% | 31.7% | ||
| Q2 24 | 23.4% | 35.8% | ||
| Q1 24 | 1.0% | 38.0% |
资本支出强度
CCRN
PRGS
| Q4 25 | 0.9% | 1.1% | ||
| Q3 25 | 0.9% | 0.4% | ||
| Q2 25 | 0.7% | 0.2% | ||
| Q1 25 | 0.6% | 0.5% | ||
| Q4 24 | 0.8% | 1.3% | ||
| Q3 24 | 0.4% | 0.6% | ||
| Q2 24 | 0.8% | 0.5% | ||
| Q1 24 | 0.6% | 0.2% |
现金转化率
CCRN
PRGS
| Q4 25 | — | 2.44× | ||
| Q3 25 | — | 3.78× | ||
| Q2 25 | — | 1.76× | ||
| Q1 25 | — | 6.30× | ||
| Q4 24 | — | 17.13× | ||
| Q3 24 | 2.92× | 2.03× | ||
| Q2 24 | — | 3.93× | ||
| Q1 24 | 2.23× | 3.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
PRGS
| Maintenanceand Services | $187.5M | 74% |
| Share File Acquisition | $67.5M | 27% |